Navigation Links
Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
Date:9/8/2013

New York, New York (PRWEB) September 08, 2013

As Pradaxa lawsuit (http://www.pradaxalawsuithelp.com/) claims continue to move forward in courts around the country, Bernstein Liebhard LLP notes that a newly-published study has reported that Pradaxa is no safer or effective than warfarin when used to treat people with mechanical heart valves. The study, called RE-ALIGN, was halted early after it became apparent that Pradaxa patients were more likely to suffer thromboembolic events, including strokes, heart attacks and blood clots, as well as internal bleeding, compared to those treated with warfarin, a blood thinner that has been on the market for decades. The study appears in the September 1, 2013 issue of the New England Journal of Medicine.*

“It’s disturbing to note that this study had to be halted early because of the high rates of Pradaxa side effects, including internal bleeding. This research is just another reminder that the risks and benefits of Pradaxa need to be more fully evaluated,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to patients who suffered serious internal bleeding while using this blood thinner.

Pradaxa Lawsuits
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. In December, shortly after the RE-ALIGN trial was halted, the FDA announced that a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves.

According to a report from Bloomberg.com, Pradaxa was touted as an improvement over warfarin, a blood thinner sold under the brand name Coumadin. However, unlike warfarin, there is no readily available antidote to stop Pradaxa bleeding.** According to the Institute for Safe Medicine Practices (ISMP), an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.***

According to court documents, more than 1,470 Pradaxa lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois on behalf of alleged victims of Pradaxa bleeding. All of the complaints accuse Boehringer Ingelheim of selling the blood thinner despite knowing it could cause fatal bleeding in some patients, and failing to adequately warn that there was no readily-available antidote for Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Alleged victims of Pradaxa bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Read More about Pradaxa side effects at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

*nejm.org/doi/full/10.1056/NEJMoa1300615, NEJM, September 1, 2013
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
***ismp.org/quarterwatch/pdfs/2012Q2.pdf, QuarterWatch, January 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11100071.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
2. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
3. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
4. Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
5. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Scheduling of Next Case Management Conference in Federal Pradaxa Bleeding Litigation
7. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
9. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
10. Pradaxa Lawsuit Attorneys at Wright & Schulte LLC Report on Scheduling of Bellwether Trials in Federal Pradaxa Bleeding Lawsuits
11. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... During the last ... provide free screening colonoscopies to eligible individuals in the local community. , Colon ... but regular screenings can detect colon cancer while it is small, confined and easier ...
(Date:3/29/2017)... FL (PRWEB) , ... March 30, 2017 , ... Grass pollen is the main cause ... allergic to the stuff. The season for grass pollen runs from May to July each ... a hay fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an ...
(Date:3/29/2017)... ... 2017 , ... Wells Pharmacy Network, a proud A4M Platinum ... World Congress, in Hollywood Florida April 6-8, 2017. , Ben David, CEO of ... in the training of physicians, scientists, and members of the public on anti-aging ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
(Date:3/29/2017)... ... March 29, 2017 , ... An inventor from Raynham, Mass., ... used in conjunction with my braces always rubbed against the inside of my ... prevent this problem." The O.B.S. was the result of his brainstorming. , This ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... N.Y. , March 29, 2017  BioSpecifics ... originated and continues to develop collagenase based-therapies with ... histolyticum (CCH) marketed as XIAFLEX ®  in the ... management will present a corporate overview at the ... on Wednesday, April 5, 2017 at 8:00 a.m. ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Italy ... report to their offering. ... Proton Therapy Market in Italy will double by ... currently three proton therapy centers in Italy that ... Italy , the first patients were treated with proton beams in ...
(Date:3/29/2017)... 29, 2017 Research and Markets has ... 2014 - 2025" report to their offering. ... The global ... million by 2025. Increasing geriatric population prone to orthopedic diseases ... navigation systems over the forecast period. Osteoarthritis and osteoporosis are ...
Breaking Medicine Technology: